Literature DB >> 759618

Morphine-induced mydriasis and fluctuation in the rat: time and dose relationships.

H Klemfuss, R J Tallarida, C H Adler, M W Adler.   

Abstract

The purpose of this investigation was to establish complete dose- and time-response relationships of morphine action on the rat pupil using serial observations. Adult male, albino rats of the Sprague-Dawley strain were used. Pupil size was measured by a series of photographs taken every 60 sec for at least 90 min under dim red illumination. The pupil began to dilate within 20 min after s.c. administration of doses of morphine sulfate as low as 1 mg/kg. The dose-related mydriasis reached a maximum with a dose of 32 mg/kg at 35 to 50 min after injection and lasted for 3 to 4 hr. The mydriasis was characterized by a rapid and marked fluctuation which was also dose-related and reached a peak with 32 mg/kg of morphine sulfate. Naloxone HCl (1 mg/kg) rapidly reversed both the mydriasis and the oscillation, thereby implicating an opiate receptor-mediated mechanism. In addition to providing a convenient measure of narcotic actions, the pupil may offer a particularly useful means for studying opiate receptor mechanisms since it is one of the few cases where, in many species, the anatomical pathways and neurochemical innervations are known.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 759618

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  3 in total

1.  Pharmacodynamics and biophasic drug levels of methionine enkephalin.

Authors:  R J Erb; L M Her; A Abdallah; A K Mitra
Journal:  Pharm Res       Date:  1991-07       Impact factor: 4.200

2.  Antagonism of opiate mydriasis in mice.

Authors:  A D Korczyn; M Rock
Journal:  Br J Pharmacol       Date:  1981-08       Impact factor: 8.739

3.  Determining pharmacological selectivity of the kappa opioid receptor antagonist LY2456302 using pupillometry as a translational biomarker in rat and human.

Authors:  Linda M Rorick-Kehn; Jennifer W Witcher; Stephen L Lowe; Celedon R Gonzales; Mary Ann Weller; Robert L Bell; John C Hart; Anne B Need; Jamie H McKinzie; Michael A Statnick; Jeffrey G Suico; David L McKinzie; Sitra Tauscher-Wisniewski; Charles H Mitch; Randall R Stoltz; Conrad J Wong
Journal:  Int J Neuropsychopharmacol       Date:  2014-10-31       Impact factor: 5.176

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.